Seeking AlphaMon, 22 Jun 2026 11:30:38 GMTInsmed: Extensive Phase 3 TPIP Program And Revenue Growth In Q1 2026, Strong BuyINSM+1.28%
Seeking AlphaTue, 09 Jun 2026 17:22:09 GMTInsmed Incorporated (INSM) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 TranscriptINSM+1.28%
Seeking AlphaWed, 20 May 2026 16:50:56 GMTInsmed Incorporated (INSM) Presents at RBC Capital Markets Global Healthcare Conference 2026 TranscriptINSM+1.28%
MarketBeatMon, 18 May 2026 07:04:09 GMTInsmed CEO Defends BRINSUPRI Launch as Sales Surge, TPIP Pipeline Gains FocusINSM+1.28%
Seeking AlphaTue, 12 May 2026 23:20:46 GMTInsmed Incorporated (INSM) Presents at Bank of America Global Healthcare Conference 2026 TranscriptINSM+1.28%
Zacks Investment ResearchFri, 08 May 2026 15:06:26 GMTInsmed's Q1 Earnings Beat, Sales Miss Estimates, Stock Tanks 23%INSM+1.28%
Seeking AlphaThu, 07 May 2026 18:51:18 GMTInsmed Incorporated (INSM) Q1 2026 Earnings Call TranscriptINSM+1.28%
Investors Business DailyThu, 07 May 2026 15:03:53 GMTInsmed Tanks On Its Most Important Launch; Why Analysts Remain BullishINSM+1.28%
Zacks Investment ResearchThu, 07 May 2026 13:56:02 GMTInsmed (INSM) Reports Q1 Loss, Misses Revenue EstimatesINSM+1.28%
Zacks Investment ResearchThu, 30 Apr 2026 15:06:07 GMTInsmed (INSM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?INSM+1.28%
Zacks Investment ResearchWed, 08 Apr 2026 13:41:11 GMTInsmed Ends Brinsupri Development in Skin Disease Post Study FailureINSM+1.28%
Seeking AlphaWed, 01 Apr 2026 11:30:38 GMTInsmed: The Pipeline Is Catching Up To The ValuationINSM+1.28%
Zacks Investment ResearchTue, 31 Mar 2026 07:51:06 GMTInsmed (INSM) Soars 5.5%: Is Further Upside Left in the Stock?INSM+1.28%
